ChemicalBook >> CAS DataBase List >>Cabozantinib impurity DX2

Cabozantinib impurity DX2

CAS No.
1628530-38-0
Chemical Name:
Cabozantinib impurity DX2
Synonyms
Cabozantinib Impurity 78;Cabozantinib impurity 65;Cabozantinib impurity DX2;Cabozantinib Metabolite M9;Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A);N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity)
CBNumber:
CB55590037
Molecular Formula:
C28H24FN3O6
Molecular Weight:
517.51
MDL Number:
MOL File:
1628530-38-0.mol
Last updated:2023-05-15 10:43:29

Cabozantinib impurity DX2 Properties

Boiling point 781.8±60.0 °C(Predicted)
Density 1.447±0.06 g/cm3(Predicted)
pka 8.42±0.40(Predicted)
FDA UNII XU28OQ19RG

Cabozantinib impurity DX2 Chemical Properties,Uses,Production

Uses

2-??Hydroxy Cabozantinib is a metabolite of cabozantinib (CAS# 849217-68-1), which is a tyrosine kinase inhibitor and an anticancer drug used in the treatment of thyroid cancer, renal cell carcinoma and hepatocellular carcinoma.

Cabozantinib impurity DX2 Preparation Products And Raw materials

Raw materials

Preparation Products

Cabozantinib impurity DX2 Suppliers

Global( 15)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656 greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761 3003392093@qq.com China 7851 55
Zhaoqing Wanwei New Material Technology Co., Ltd. 0755-1328880-4488 13068786899 13288804488@163.com China 625 58
Shenzhen ruikai de biotechnology co., ltd. 0755-61348847 17820674378 2682116078@qq.com China 7844 58
Wuhan chuanghao Biotechnology Co., Ltd 13361917963 876725023@qq.com China 297 58
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd 755-22677922-801 18126518403 2851922760@qq.com China 5043 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396 ORDERS@QCSRM.COM China 18810 58
Nanjing Shanyao Kangcheng biomedical Co., Ltd. 15722982350 1170703875@qq.com China 516 58
Bide Pharmatech Ltd. 400-1647117 15221909166 product02@bidepharm.com China 61720 58
Bide Pharmatech Ltd. 400-6005915 sales@picasso-e.com China 39668 58
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)-1,1-cyclopropanedicarboxamide Cabozantinib impurity DX2 Cabozantinib impurity 65 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-2-hydroxyphenyl)- N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide Cabozantinib Metabolite M9 Cabozantinib Impurity 78 Tributyl Acetylcitrate Impurity 1 (Tributyl Acetylcitrate EP Impurity A) N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-2-hydroxyphenyl)cyclopropane-1,1-dicarboxamide? (Cabozantinib Impurity) 1628530-38-0